Back to Search Start Over

KCNC1-related disorders: New de novo variants expand the phenotypic spectrum

Authors :
Park, Joohyun
Koko, Mahmoud
Hedrich, Ulrike B. S.
Hermann, Andreas
Cremer, Kirsten
Haberlandt, Edda
Grimmel, Mona
Alhaddad, Bader
Beck‐Woedl, Stefanie
Harrer, Merle
Karall, Daniela
Kingelhoefer, Lisa
Tzschach, Andreas
Matthies, Lars C.
Strom, Tim M.
Ringelstein, Erich Bernd
Sturm, Marc
Engels, Hartmut
Wolff, Markus
Lerche, Holger
Haack, Tobias B.
Source :
Ann. Clin. Transl. Neurol. 6, 1319-1326 (2019), Annals of Clinical and Translational Neurology 6(7), 1319-1326 (2019). doi:10.1002/acn3.50799, Annals of Clinical and Translational Neurology, Vol 6, Iss 7, Pp 1319-1326 (2019), Annals of Clinical and Translational Neurology
Publication Year :
2019
Publisher :
Wiley, 2019.

Abstract

A recurrent de novo missense variant in KCNC1, encoding a voltage‐gated potassium channel expressed in inhibitory neurons, causes progressive myoclonus epilepsy and ataxia, and a nonsense variant is associated with intellectual disability. We identified three new de novo missense variants in KCNC1 in five unrelated individuals causing different phenotypes featuring either isolated nonprogressive myoclonus (p.Cys208Tyr), intellectual disability (p.Thr399Met), or epilepsy with myoclonic, absence and generalized tonic‐clonic seizures, ataxia, and developmental delay (p.Ala421Val, three patients). Functional analyses demonstrated no measurable currents for all identified variants and dominant‐negative effects for p.Thr399Met and p.Ala421Val predicting neuronal disinhibition as the underlying disease mechanism.

Details

Language :
English
Database :
OpenAIRE
Journal :
Ann. Clin. Transl. Neurol. 6, 1319-1326 (2019), Annals of Clinical and Translational Neurology 6(7), 1319-1326 (2019). doi:10.1002/acn3.50799, Annals of Clinical and Translational Neurology, Vol 6, Iss 7, Pp 1319-1326 (2019), Annals of Clinical and Translational Neurology
Accession number :
edsair.pmid.dedup....d3d4acb026b42a192bc809ac6e0e1676